Nano Flow’s Influenza B (Flu B) gold conjugate is built on a monoclonal antibody targeting the Influenza B nucleoprotein, a highly conserved antigen across Influenza B strains. Validated as a detection antibody in lateral flow assays, this conjugate delivers sensitive and specific performance for Influenza B diagnostics. The corresponding capture antibody is also available, providing assay developers with a complete antibody pair for rapid test development.
Influenza B (Flu B) Gold Conjugate – 40 nm (Ref NF-FLUB-AU)
This antibody demonstrates no cross-reactivity with Influenza A, adenovirus, RSV, parainfluenza, Mycoplasma pneumoniae, or SARS-CoV-2, ensuring diagnostic accuracy and reliability. Produced on Nano Flow’s highly spherical 40 nm gold nanoparticles (OD20), it offers reproducibility, long-term stability, and strong visual signals across immunoassay formats.
Applications: Lateral flow assays (LF) and other immunoassay formats.
Certificate of Analysis: Supplied with each batch, including TEM, DLS, and UV-Vis characterization.
Technical Specifications
| Parameter | Specification |
|---|---|
| Antibody format | IgG1 |
| Host | CHO cells |
| Clonality | Monoclonal |
| Specificity | Influenza B nucleoprotein |
| Cross-reactivity | None with Influenza A, adenovirus, RSV, parainfluenza, M. pneumoniae, or SARS-CoV-2 |
| Gold nanoparticle size | 40 nm |
| Concentration of the gold conjugate | OD20 |
| Buffer | Borate, BSA 0.25%, NaN₃ 0.09%, pH 7.3 |
| Shelf life | 1 year |
| Available volumes | From 1 ml to 1 L+ |
